• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算无尿和无透析液收集的持续性不卧床腹膜透析患者的总小分子溶质清除率。

Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collection.

机构信息

Department of Nephrology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Key Laboratory of Nephrology (Sun Yat-sen University), Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.

出版信息

Perit Dial Int. 2020 Jan;40(1):84-92. doi: 10.1177/0896860819878658.

DOI:10.1177/0896860819878658
PMID:32063147
Abstract

BACKGROUND

International Society for Peritoneal Dialysis guidelines recommend to routinely monitor the total measured clearance (mCl) of small solutes such as creatinine; however, collection of 24-h urine and peritoneal dialysis (PD) fluid is burdensome to patients and prone to errors. We hypothesized that equations could be developed to estimate mCl (estimated clearance (eCl)) using endogenous filtration markers.

METHODS

In the Guangzhou PD Study ( = 980), we developed eCl equations using linear regression in two-third and validated them in the remaining one-third. Reference tests were mCl for urea nitrogen (UN) (mCl, ml/min) and average mCl for UN and creatinine (mCl, ml/min/1.73 m). Index tests were various eCl equations using UN, creatinine, low-molecular-weight proteins (LMWPs) (beta-trace protein (BTP), beta-2 microglobulin (B2M), and cystatin C), demographic variables, and body size. After reexpression of the equations in the combined data set, we analyzed accuracy (eCl within ± 2.0 units of mCl) and the predictive value of eCl to detect a weekly total standard Kt/V (weekly mCl indexed for total body water) > 1.7 using receiver operating characteristic curve.

RESULTS

Mean age of the cohort was 50 ± 15 years, 53% were male; mCl was 6.9 ± 1.8 and mCl was 7.5 ± 2.8. Creatinine but not UN contributed to eCl for both mCl. LMWP did not improve accuracy for mCl (range 88-89%). BTP and B2M improved the accuracy for mCl (82% vs. 80%); however, differences were small. The area under the curve for predicting a weekly Kt/V > 1.7 was similar for all equations (range 0.79-0.80).

CONCLUSIONS

Total small solute clearance can be estimated moderately well in continuous ambulatory PD patients using serum creatinine and demographic variables without urine and dialysate collection.

摘要

背景

国际腹膜透析学会指南建议常规监测小分子溶质(如肌酐)的总测量清除率(mCl);然而,收集 24 小时尿液和腹膜透析(PD)液对患者来说是负担,并且容易出错。我们假设可以开发使用内源性滤过标志物来估计 mCl(估计清除率(eCl))的方程。

方法

在广州 PD 研究( = 980)中,我们使用三分之二的线性回归开发了 eCl 方程,并在剩余的三分之一中进行了验证。参考测试是用于尿素氮(UN)的 mCl(mCl,ml/min)和用于 UN 和肌酐的平均 mCl(mCl,ml/min/1.73 m)。指标测试是使用 UN、肌酐、低分子量蛋白(LMWP)(β-痕迹蛋白(BTP)、β-2 微球蛋白(B2M)和胱抑素 C)、人口统计学变量和体型的各种 eCl 方程。在组合数据集重新表达方程后,我们分析了准确性(eCl 在 mCl 的±2.0 单位内)和 eCl 预测检测每周总标准 Kt/V(每周 mCl 索引为总体水)>1.7 的价值使用接收者操作特征曲线。

结果

队列的平均年龄为 50±15 岁,53%为男性;mCl 为 6.9±1.8,mCl 为 7.5±2.8。肌酐而非 UN 为两者的 eCl 做出了贡献。LMWP 并未提高 mCl 的准确性(范围 88-89%)。BTP 和 B2M 提高了 mCl 的准确性(82%对 80%);然而,差异很小。所有方程预测每周 Kt/V>1.7 的曲线下面积相似(范围 0.79-0.80)。

结论

在连续非卧床 PD 患者中,使用血清肌酐和人口统计学变量可以很好地估计总小分子清除率,而无需收集尿液和透析液。

相似文献

1
Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collection.估算无尿和无透析液收集的持续性不卧床腹膜透析患者的总小分子溶质清除率。
Perit Dial Int. 2020 Jan;40(1):84-92. doi: 10.1177/0896860819878658.
2
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients.透析患者残余肾功能估计方程的开发与验证
Kidney Med. 2019 May 11;1(3):104-114. doi: 10.1016/j.xkme.2019.04.002. eCollection 2019 May-Jun.
3
Creatinine clearance in continuous peritoneal dialysis: dialysis dose required for a minimal acceptable level.持续非卧床腹膜透析患者的肌酐清除率:达到最低可接受水平所需的透析剂量
Perit Dial Int. 1996 Jan-Feb;16(1):41-7.
4
Roles of peritoneal clearance and residual kidney removal in control of uric acid in patients on peritoneal dialysis.腹膜清除和残余肾去除在腹膜透析患者尿酸控制中的作用。
BMC Nephrol. 2020 Apr 25;21(1):148. doi: 10.1186/s12882-020-01800-1.
5
Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures.采用β-痕迹蛋白估算残余肾功能:透析程序的影响。
Artif Organs. 2020 Jun;44(6):647-654. doi: 10.1111/aor.13641. Epub 2020 Mar 5.
6
Estimating residual kidney function in dialysis patients without urine collection.在不收集尿液的情况下估算透析患者的残余肾功能。
Kidney Int. 2016 May;89(5):1099-1110. doi: 10.1016/j.kint.2015.10.011. Epub 2016 Jan 21.
7
Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.血清胱抑素C与腹膜透析中腹膜和肾脏清除率指标的关系:一项横断面研究。
Am J Kidney Dis. 2008 Feb;51(2):278-84. doi: 10.1053/j.ajkd.2007.08.018.
8
Association of Alternative Approaches to Normalizing Peritoneal Dialysis Clearance with Mortality and Technique Failure: A Retrospective Analysis Using the United States Renal Data System-Dialysis Morbidity and Mortality Study, Wave 2.腹膜透析清除率正常化的替代方法与死亡率和技术失败的关联:使用美国肾脏数据系统-透析发病率和死亡率研究第2波的回顾性分析
Perit Dial Int. 2017;37(1):85-93. doi: 10.3747/pdi.2015.00227. Epub 2016 Sep 28.
9
Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.不同类型腹膜溶质转运的持续性腹膜透析患者的腹膜尿素和肌酐清除率
Kidney Int. 1998 May;53(5):1405-11. doi: 10.1046/j.1523-1755.1998.00896.x.
10
Peritoneal dialysis adequacy and risk of death.腹膜透析充分性与死亡风险
Kidney Int. 2000 Jul;58(1):446-57. doi: 10.1046/j.1523-1755.2000.00184.x.